
    
      Apparently healthy individuals with metabolic syndrome were prospectively and consecutively
      enrolled since August 2017. Blood samples were obtained after participants are fasting for at
      least 12 hours, including serum uric acid, high-sensitivity C-reactive protein,
      high-sensitivity interleukin-6, tumor necrotizing factor alpha, fasting glucose, glycosylated
      hemoglobin, insulin, lipid profile, creatinine, alanine aminotransferase, sodium, potassium,
      and calcium. All echocardiographic parameters were measured in accordance with the American
      Society of Echocardiography guidelines.
    
  